Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China flag China · Delayed Price · Currency is CNY
16.16
-0.19 (-1.16%)
May 20, 2026, 11:25 AM CST

SHE:002603 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
7,8977,8156,50610,31512,52010,111
Other Revenue
15.7415.746.993.4813.046.12
7,9127,8316,51310,31812,53310,117
Revenue Growth (YoY)
24.64%20.24%-36.88%-17.67%23.88%15.19%
Cost of Revenue
2,7602,8753,4864,4344,5563,700
Gross Profit
5,1524,9563,0275,8847,9766,417
Selling, General & Admin
2,5842,4992,9353,2973,8713,931
Research & Development
728.01718.25826.57853.191,032792.16
Other Operating Expenses
141.66123.6591.7299.27203.45138.41
Operating Expenses
3,4733,3513,8644,2715,1234,898
Operating Income
1,6791,605-837.021,6132,8531,519
Interest Expense
-1.29-1.06-29.01-38.9-33.8-33.97
Interest & Investment Income
12.28.5947.8142.0412.920.45
Currency Exchange Gain (Loss)
-1.93-1.931.46-0.214.16-1.25
Other Non Operating Income (Expenses)
-1.62-4.4-2.62-4.83-49.4-3.31
EBT Excluding Unusual Items
1,6861,606-819.391,6112,7871,501
Impairment of Goodwill
-6.24-6.24-6.24-0.52--
Gain (Loss) on Sale of Investments
5.273.92-39.3511.5-21.9
Gain (Loss) on Sale of Assets
-1.04-0.89-0.49-0.82-3.11-3.37
Asset Writedown
-49.28-65.98-0.77-10.63-95.62-9.91
Other Unusual Items
51.4454.3226.6845.8880.5688.23
Pretax Income
1,6871,592-800.191,6842,7811,554
Income Tax Expense
320.4309.88-66.01339.91422.87212.09
Earnings From Continuing Operations
1,3661,282-734.181,3442,3581,342
Minority Interest in Earnings
3.194.759.678.084.982.22
Net Income
1,3691,286-724.521,3522,3631,344
Net Income to Common
1,3691,286-724.521,3522,3631,344
Net Income Growth
----42.76%75.82%10.27%
Shares Outstanding (Basic)
1,6711,6711,6711,6711,6711,671
Shares Outstanding (Diluted)
1,6711,6711,6711,6711,6711,671
Shares Change (YoY)
0.02%0.01%-0.01%-0.01%0.01%-0.00%
EPS (Basic)
0.820.77-0.430.811.410.80
EPS (Diluted)
0.820.77-0.430.811.410.80
EPS Growth
----42.76%75.81%10.27%
Free Cash Flow
1,7861,531320.62-155.383,274-144.87
Free Cash Flow Per Share
1.070.920.19-0.091.96-0.09
Dividend Per Share
0.8000.800-0.3000.5000.300
Dividend Growth
----40.00%66.67%-58.00%
Gross Margin
65.11%63.29%46.47%57.03%63.64%63.43%
Operating Margin
21.22%20.50%-12.85%15.63%22.77%15.01%
Profit Margin
17.31%16.43%-11.13%13.11%18.85%13.28%
Free Cash Flow Margin
22.57%19.55%4.92%-1.51%26.12%-1.43%
EBITDA
2,2972,220-235.582,1533,2941,871
EBITDA Margin
29.04%28.35%-3.62%20.87%26.28%18.50%
D&A For EBITDA
618.32614.94601.44540.64440.6352.61
EBIT
1,6791,605-837.021,6132,8531,519
EBIT Margin
21.22%20.50%-12.85%15.63%22.77%15.01%
Effective Tax Rate
19.00%19.47%-20.18%15.21%13.65%
Revenue as Reported
7,9127,8316,51310,31812,53310,117
Advertising Expenses
-114.07169.83257.93--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.